Immunogenetic Association Underlying Severe COVID-19
SARS-CoV2 has caused the current pandemic of new coronavirus disease 2019 (COVID-19) worldwide. Clinical outcomes of COVID-19 illness range broadly from asymptotic and mild to a life-threatening situation. This casts uncertainties for defining host determinants underlying the disease severity. Recen...
Main Authors: | Kendall McCoy, Autumn Peterson, Yun Tian, Yongming Sang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/8/4/700 |
Similar Items
-
Dysregulated Interferon Response Underlying Severe COVID-19
by: LeAnn Lopez, et al.
Published: (2020-12-01) -
The MEK Inhibitors Trametinib and Cobimetinib Induce a Type I Interferon Response in Human Keratinocytes
by: Daniela Lulli, et al.
Published: (2017-10-01) -
Epigenetic Evolution of ACE2 and IL-6 Genes: Non-Canonical Interferon-Stimulated Genes Correlate to COVID-19 Susceptibility in Vertebrates
by: Eric R. Sang, et al.
Published: (2021-01-01) -
The Importance of Context: Uncovering Species- and Tissue-Specific Effects of Genetic Risk Variants for Type 2 Diabetes
by: Soren Krogsgaard Thomsen, et al.
Published: (2016-08-01) -
Immunogenetics of chemokines in childhood asthma.
Published: (2004)